| Term 
 
        | Decreased Delivery to site of Action Decreased GI absorption |  | Definition 
 
        | 
Binding
Cholestyramine + levothyroxine → ↓ levothyroxine absorption Antacids (Ca, Al, Mg) + tetracycline → chelate formation with ↓ tetracycline absorption ferrous sulfate + tetracycline → ↓ tetracycline absorption Altered gut motility-no example givenAltered pH gastrointestinal fluid
cimetidine (or ranitidine) + ketoconazole → ↓ ketoconazole absMay be due to decreased ketoconazole dissolution at ↑ pHcimetidine should be given 2 hrs after ketaconazole fluconazole + cimetidine (oral) → ↓ fluconazole absfluconazole + cimetidine (IV) → fluconazole abs does not change  |  | 
        |  | 
        
        | Term 
 
        | Decreased delivery to site of action Decreased transport to cellular site of action |  | Definition 
 
        | 
tricyclic antidepressents + guanethidine →                 ↓ guanethidine uptake by sympathetic nerve endings → ↓ anti-hypertensive effectsephedrine, amphetamines, phenothiazines have similar effect |  | 
        |  | 
        
        | Term 
 
        | Decreased delivery to site of action Enhanced Elimination |  | Definition 
 
        | 
Enzyme Stimulation
Examples of INDUCERS of CYP inculde phenobarbital, carbamazepine, phenytoin, rifampin, St, Johns WartPhenobarbital + warfarin → ↓ anticoagulant effect (↓ plasma levels of warfarin) Interactions with St. Johns Wart
Induction of CYP enzymes; can also induce P-glycoprotein transporterSt. Johns wart + (indinavir or cyclosporine via CYP or digoxin via p-glycoprotein) → ↓ plasma drug concentration  Increased renal elimination 
alkalinization of urine + phenobarbital → ↑ excretion of drugacidification of urine + amphetamines → ↑ excretion of drug   |  | 
        |  | 
        
        | Term 
 
        | Increased Delivery to Site of Action   |  | Definition 
 
        | 
Increased Absorption-no example givenDecreased plasma protein binding-no example givenDecreased ElinationInhibition of p-glycoprotein |  | 
        |  | 
        
        | Term 
 
        | Increased Delivery to Site of Action Decreased Elimation |  | Definition 
 
        | 
Inhibition of Xanthine Oxidase
allopurinol + azathioprine (6-MP) → ↑ toxicity due to increased levels of MPThis occurs in both IV and oral forms according to package insert Inhibition of CYP enzymes
Examples of inhibitors of CYP include amiodarone, erythromycin, ketoconazole, grapefruit juiceamiodarone + warfarin → ↓ warfarin elimination → ↑ warfarin plasma levelsKetoconazole + terfenadine (Seldane) → ↓ terfenadine elimination → ventricular arrhythmia
Ketoconazole blocks the conversion of terfenadine → fexofenadine (not active) Grapefruit juice + felodipine → ↑ plasma felodipine concentration Inhibition of monoamine oxidase
MAO inhibitor + tyramine → hypertensionMAO inhibitor + selective serotonin reuptake inhbitor → serotonin syndrome |  | 
        |  | 
        
        | Term 
 
        | Increased Delivery to Site of Action Decreased Renal Excretion |  | Definition 
 
        | 
Prodenecid + penicillin → ↓ penicillin excretionThiazide diuretic + lithium → ↓ lithium excretion   |  | 
        |  | 
        
        | Term 
 
        | Increased Delivery to Site of Action Inhibition of P-glycoprotein |  | Definition 
 
        | 
quinidine + digoxin → ↓ digoxin clearanceQuinidine reduces the clearance of digoxin; inhibition of P-glycoprotein-mediated digoxin transport has been implicated |  | 
        |  |